Berries (General) for Anti-Inflammatory

Research suggests that berries and berry-derived compounds — including anthocyanins, quercetin, pelargonidin, and other polyphenols — demonstrate meaningful anti-inflammatory properties across a range of laboratory, animal, and review-level studies, with evidence spanning blackcurrants, lingonberries, strawberries, and several lesser-known species such as Brazilian native Eugenia fruits and Campomanesia adamantium. Studies indicate these compounds may work through multiple pathways, including scavenging free radicals, reducing pro-inflammatory signaling molecules like TNF-α and NF-κB, and modulating immune cell activity, with supporting evidence from animal models, cell studies, and numerous narrative reviews. The body of literature is largely preclinical and observational in nature, with the available randomized controlled trial touching only indirectly on berry-related anti-inflammatory effects, and at least one study examining dietary inflammatory patterns found no statistically significant link to a common inflammation marker in a general adult population. Overall, while the convergent direction of the evidence is encouraging, most researchers across these studies emphasize that well-designed human clinical trials are still needed before firm conclusions can be drawn about the magnitude or consistency of berries' anti-inflammatory effects in people.